Morgan Stanley’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$325M Buy
1,485,097
+199,751
+16% +$43.7M 0.02% 648
2025
Q1
$288M Buy
1,285,346
+252,175
+24% +$56.5M 0.02% 679
2024
Q4
$338M Buy
1,033,171
+61,686
+6% +$20.2M 0.02% 617
2024
Q3
$292M Buy
971,485
+301,449
+45% +$90.5M 0.02% 659
2024
Q2
$221M Buy
670,036
+3,157
+0.5% +$1.04M 0.02% 759
2024
Q1
$264M Sell
666,879
-1,380,825
-67% -$546M 0.02% 674
2023
Q4
$721M Buy
2,047,704
+1,297,398
+173% +$457M 0.03% 527
2023
Q3
$282M Buy
750,306
+60,927
+9% +$22.9M 0.03% 572
2023
Q2
$264M Sell
689,379
-25,558
-4% -$9.78M 0.03% 609
2023
Q1
$248M Sell
714,937
-36,405
-5% -$12.6M 0.03% 618
2022
Q4
$177M Buy
751,342
+123,992
+20% +$29.2M 0.02% 739
2022
Q3
$154M Sell
627,350
-13,301
-2% -$3.27M 0.02% 684
2022
Q2
$194M Buy
640,651
+258,710
+68% +$78.2M 0.03% 602
2022
Q1
$157M Sell
381,941
-148,818
-28% -$61.1M 0.02% 631
2021
Q4
$249M Buy
530,759
+156,656
+42% +$73.5M 0.03% 481
2021
Q3
$159M Sell
374,103
-191,375
-34% -$81.2M 0.02% 618
2021
Q2
$203M Buy
565,478
+250,453
+80% +$89.9M 0.03% 539
2021
Q1
$88.8M Buy
315,025
+73,977
+31% +$20.8M 0.01% 821
2020
Q4
$68.3M Buy
241,048
+31,783
+15% +$9M 0.01% 900
2020
Q3
$57.5M Buy
209,265
+50,807
+32% +$14M 0.01% 838
2020
Q2
$36M Buy
158,458
+110,415
+230% +$25.1M 0.01% 1030
2020
Q1
$7.32M Sell
48,043
-42,033
-47% -$6.4M ﹤0.01% 2072
2019
Q4
$13.5M Sell
90,076
-121,254
-57% -$18.2M ﹤0.01% 2069
2019
Q3
$30M Buy
211,330
+184,407
+685% +$26.2M 0.01% 1194
2019
Q2
$3.37M Buy
26,923
+8,848
+49% +$1.11M ﹤0.01% 3314
2019
Q1
$1.99M Sell
18,075
-211,293
-92% -$23.3M ﹤0.01% 3582
2018
Q4
$22.5M Sell
229,368
-14,665
-6% -$1.44M 0.01% 1368
2018
Q3
$30.1M Buy
244,033
+144,230
+145% +$17.8M 0.01% 1324
2018
Q2
$9.91M Sell
99,803
-168,885
-63% -$16.8M ﹤0.01% 2389
2018
Q1
$23.7M Buy
268,688
+74,551
+38% +$6.58M 0.01% 1513
2017
Q4
$19.2M Buy
194,137
+28,929
+18% +$2.85M 0.01% 1707
2017
Q3
$15.9M Sell
165,208
-219,325
-57% -$21.1M ﹤0.01% 1796
2017
Q2
$36.3M Buy
384,533
+93,724
+32% +$8.86M 0.01% 1083
2017
Q1
$23.7M Buy
290,809
+170,008
+141% +$13.9M 0.01% 1415
2016
Q4
$10.2M Sell
120,801
-112,894
-48% -$9.58M ﹤0.01% 2233
2016
Q3
$17.4M Buy
233,695
+33,350
+17% +$2.48M 0.01% 1569
2016
Q2
$15.2M Buy
200,345
+182,996
+1,055% +$13.9M 0.01% 1645
2016
Q1
$1.2M Sell
17,349
-35,640
-67% -$2.47M ﹤0.01% 3783
2015
Q4
$3.19M Buy
52,989
+9,628
+22% +$580K ﹤0.01% 3086
2015
Q3
$2.35M Buy
43,361
+7,843
+22% +$425K ﹤0.01% 3362
2015
Q2
$2.06M Sell
35,518
-6,359
-15% -$369K ﹤0.01% 3599
2015
Q1
$2.52M Buy
41,877
+1,127
+3% +$67.8K ﹤0.01% 3381
2014
Q4
$2.17M Sell
40,750
-4,577
-10% -$244K ﹤0.01% 3497
2014
Q3
$2.03M Sell
45,327
-201,101
-82% -$9M ﹤0.01% 3420
2014
Q2
$10.4M Buy
246,428
+44,128
+22% +$1.86M ﹤0.01% 2004
2014
Q1
$8.91M Sell
202,300
-52,712
-21% -$2.32M ﹤0.01% 2051
2013
Q4
$12.5M Buy
255,012
+150,142
+143% +$7.37M 0.01% 1755
2013
Q3
$4.32M Sell
104,870
-8,708
-8% -$358K ﹤0.01% 2582
2013
Q2
$3.99M Buy
+113,578
New +$3.99M ﹤0.01% 2549